122 related articles for article (PubMed ID: 28035384)
21. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling.
van de Geijn GJ; Gits J; Touw IP
J Leukoc Biol; 2004 Jul; 76(1):237-44. PubMed ID: 15107455
[TBL] [Abstract][Full Text] [Related]
22. The intracellular delivery of a recombinant peptide derived from the acidic domain of PIAS3 inhibits STAT3 transactivation and induces tumor cell death.
Borghouts C; Tittmann H; Delis N; Kirchenbauer M; Brill B; Groner B
Mol Cancer Res; 2010 Apr; 8(4):539-53. PubMed ID: 20371673
[TBL] [Abstract][Full Text] [Related]
23. The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling.
Fischer P; Lehmann U; Sobota RM; Schmitz J; Niemand C; Linnemann S; Haan S; Behrmann I; Yoshimura A; Johnston JA; Müller-Newen G; Heinrich PC; Schaper F
Biochem J; 2004 Mar; 378(Pt 2):449-60. PubMed ID: 14611646
[TBL] [Abstract][Full Text] [Related]
24. Trichostatin A, a histone deacetylase inhibitor, suppresses JAK2/STAT3 signaling via inducing the promoter-associated histone acetylation of SOCS1 and SOCS3 in human colorectal cancer cells.
Xiong H; Du W; Zhang YJ; Hong J; Su WY; Tang JT; Wang YC; Lu R; Fang JY
Mol Carcinog; 2012 Feb; 51(2):174-84. PubMed ID: 21520296
[TBL] [Abstract][Full Text] [Related]
25. Expression of interleukin-8 receptor CXCR2 and suppressor of cytokine signaling-3 in astrocytic tumors.
Korkolopoulou P; Levidou G; El-Habr EA; Adamopoulos C; Samaras V; Zisakis A; Kavantzas N; Boviatsis E; Fragkou P; Papavassiliou AG; Patsouris E; Piperi C
Mol Med; 2012 May; 18(1):379-88. PubMed ID: 22231733
[TBL] [Abstract][Full Text] [Related]
26. A novel pro-inflammatory mechanism of action of resistin in human endothelial cells: up-regulation of SOCS3 expression through STAT3 activation.
Pirvulescu M; Manduteanu I; Gan AM; Stan D; Simion V; Butoi E; Calin M; Simionescu M
Biochem Biophys Res Commun; 2012 Jun; 422(2):321-6. PubMed ID: 22575502
[TBL] [Abstract][Full Text] [Related]
27. Nuclear unphosphorylated STAT3 correlates with a worse prognosis in human glioblastoma.
Rodrigues BR; Queiroz-Hazarbassanov N; Lopes MH; Bleggi-Torres LF; Suzuki S; Cunha IW; Sanematsu P; Martins VR
Pathol Res Pract; 2016 Jun; 212(6):517-23. PubMed ID: 27013058
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in human cutaneous melanoma.
Wu ZS; Cheng XW; Wang XN; Song NJ
Melanoma Res; 2011 Dec; 21(6):483-90. PubMed ID: 21876460
[TBL] [Abstract][Full Text] [Related]
29. Low PIAS3 expression in malignant mesothelioma is associated with increased STAT3 activation and poor patient survival.
Dabir S; Kluge A; Kresak A; Yang M; Fu P; Groner B; Wildey G; Dowlati A
Clin Cancer Res; 2014 Oct; 20(19):5124-32. PubMed ID: 25124686
[TBL] [Abstract][Full Text] [Related]
30. Nucleocytoplasmic shuttling of persistently activated STAT3.
Herrmann A; Vogt M; Mönnigmann M; Clahsen T; Sommer U; Haan S; Poli V; Heinrich PC; Müller-Newen G
J Cell Sci; 2007 Sep; 120(Pt 18):3249-61. PubMed ID: 17726064
[TBL] [Abstract][Full Text] [Related]
31. The association and nuclear translocation of the PIAS3-STAT3 complex is ligand and time dependent.
Dabir S; Kluge A; Dowlati A
Mol Cancer Res; 2009 Nov; 7(11):1854-60. PubMed ID: 19903771
[TBL] [Abstract][Full Text] [Related]
32. Both type I and II IFN induce insulin resistance by inducing different isoforms of SOCS expression in 3T3-L1 adipocytes.
Wada T; Hoshino M; Kimura Y; Ojima M; Nakano T; Koya D; Tsuneki H; Sasaoka T
Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1112-23. PubMed ID: 21386060
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia-induced decreases in SOCS3 increase STAT3 activation and upregulate VEGF gene expression.
Yokogami K; Yamashita S; Takeshima H
Brain Tumor Pathol; 2013 Jul; 30(3):135-43. PubMed ID: 23104276
[TBL] [Abstract][Full Text] [Related]
34. TRIM8 modulates STAT3 activity through negative regulation of PIAS3.
Okumura F; Matsunaga Y; Katayama Y; Nakayama KI; Hatakeyama S
J Cell Sci; 2010 Jul; 123(Pt 13):2238-45. PubMed ID: 20516148
[TBL] [Abstract][Full Text] [Related]
35. Regulation of rod photoreceptor differentiation by STAT3 is controlled by a tyrosine phosphatase.
Pinzon-Guzman C; Xing T; Zhang SS; Barnstable CJ
J Mol Neurosci; 2015 Jan; 55(1):152-159. PubMed ID: 25108518
[TBL] [Abstract][Full Text] [Related]
36. Identification and validation of SOCS1/2/3/4 as potential prognostic biomarkers and correlate with immune infiltration in glioblastoma.
Dai L; Han Y; Yang Z; Zeng Y; Liang W; Shi Z; Tao Y; Liang X; Liu W; Zhou S; Xing Z; Hu W; Wang X
J Cell Mol Med; 2023 Aug; 27(15):2194-2214. PubMed ID: 37315184
[TBL] [Abstract][Full Text] [Related]
37. Decreased expression of PIAS1 and PIAS3 in essential thrombocythemia patients.
Hsiao HH; Liu YC; Yang MY; Tsai YF; Liu TC; Chang CS; Lin SF
Genet Mol Res; 2013 Nov; 12(4):5617-22. PubMed ID: 24301930
[TBL] [Abstract][Full Text] [Related]
38. Expression of suppressor of cytokine signalling 3 (SOCS3) in human bladder epithelial cells infected with uropathogenic Escherichia coli.
Demirel I; Säve S; Kruse R; Persson K
APMIS; 2013 Feb; 121(2):158-67. PubMed ID: 23030674
[TBL] [Abstract][Full Text] [Related]
39. Expression of signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 in urothelial carcinoma.
Huang WT; Yang SF; Wu CC; Chen WT; Huang YC; Su YC; Chai CY
Kaohsiung J Med Sci; 2009 Dec; 25(12):640-6. PubMed ID: 19951849
[TBL] [Abstract][Full Text] [Related]
40. Multiple roles of SOCS proteins: differential expression of SOCS1 and SOCS3 in atherosclerosis.
Liang X; He M; Chen T; Liu Y; Tian YL; Wu YL; Zhao Y; Shen Y; Yuan ZY
Int J Mol Med; 2013 May; 31(5):1066-74. PubMed ID: 23545584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
